Yavuz Kutay Gökçe

Dr. Yavuz Kutay Gökçe

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
NŞNilgün Şahin
Nilgün Şahin
SASemih Aydemir
Semih Aydemir
NSNazan Has Selmi
Nazan Has Selmi
İEİbrahim Ertaş
İbrahim Ertaş
YGYavuz Kutay Gökçe
Yavuz Kutay Gökçe
MEMESHER ENSARİOGLU
MESHER ENSARİOGLU
Background/Objectives: This study aimed to investigate the prognostic significance of the triglyceride–glucose index (TGI), triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio, and inflammatory biomarkers in predicting short-term mortality among intensive care unit (ICU) patients with sepsis. Additionally, this study evaluated whether combining these indices with conventional clinical scores improves prognostic accuracy. Methods: This retrospective cohort study included 600 adult ICU patients diagnosed with sepsis according to Sepsis-3 criteria between January 2020 and April 2025. Clinical, biochemical, and hematological data were collected within the first 24 h of ICU admission. Metabolic indices (TGI, TG/HDL-C) and inflammatory markers (neutrophil-to-lymphocyte ratio [NLR], systemic immune-inflammation index [SII], and pan-immune-inflammation value [PIV]) were analyzed. The primary outcome was 28-day mortality. Receiver operating characteristic (ROC) analyses, Kaplan–Meier survival curves, and a multivariable logistic regression model were applied to determine prognostic performance. Results: Non-survivors exhibited significantly higher levels of TGI, TG/HDL-C, NLR, SII, and PIV compared to survivors (all p < 0.001). In ROC analysis, TGI (AUC = 0.75, 95% CI: 0.71–0.79), TG/HDL-C (AUC = 0.72, 95% CI: 0.68–0.76), and PIV (AUC = 0.78, 95% CI: 0.74–0.82) demonstrated good discriminative power for predicting 28-day mortality. Multivariate logistic regression identified TGI > 8.95 (OR = 1.44, 95% CI: 1.19–1.74, p < 0.001), TG/HDL-C > 3.95 (OR = 1.31, 95% CI: 1.08–1.59, p = 0.005), and PIV > 260 (OR = 1.49, 95% CI: 1.22–1.82, p < 0.001) as independent predictors of mortality. Integrating TGI and PIV with the SOFA score improved prognostic performance (ΔAUC = +0.04). Conclusions: Both TGI and TG/HDL-C are independent predictors of short-term mortality in septic ICU patients, reflecting the contribution of metabolic dysregulation to disease severity. The PIV demonstrated comparable predictive ability to conventional severity scores. Combining metabolic and inflammatory biomarkers with established clinical indices may enhance early risk stratification and guide personalized management strategies in sepsis.

1 January 2026 in Journal of Clinical and Analytical Medicine
Verified
Journal Article
Closed access
YGYavuz Kutay Gökçe
Yavuz Kutay Gökçe
ASArif Irfan Soykan
Arif Irfan Soykan
RERamazan Erdem Er
Ramazan Erdem Er
MOMemduh Ozden
Memduh Ozden

16 September 2026 in Archives of Current Medical Research
Verified
Journal Article
Closed access
AKAli Can Kurtipek
Ali Can Kurtipek
YGYavuz Kutay Gökçe
Yavuz Kutay Gökçe
MÇMerve Nur Çağlayan
Merve Nur Çağlayan
ÖYÖznur Elif Yalçınkaya
Öznur Elif Yalçınkaya
AKAslı Küçükekici
Aslı Küçükekici
HKHavva Keskin
Havva Keskin
Background: The global burden of diabetes continues to rise, driven by increasing prevalence, high complication rates, and substantial healthcare costs. While hospitalization is essential for acute metabolic emergencies, a considerable “grey zone” population presents with severe hyperglycemia without overt crisis, for whom the optimal care setting remains uncertain. We aimed to evaluate the clinical rationale and system-level implications of inpatient versus intensive outpatient management strategies in patients with uncontrolled diabetes.Methods: In this retrospective, single-center study, we included all adult patients for a duration of 1 year with uncontrolled diabetes who met the hospitalization criteria as recommended by clinical guidelines and personalized clinical decision-making. The patients were grouped based on whether they accepted or refused hospitalization. Both groups were treated according to the most recent guidelines, and the outcomes after six-month follow-up of admitted patients were compared to those who were treated in an outpatient setting.Results: Patients were divided into outpatient (n=72) and inpatient (n=37) groups. Groups were comparable in terms of age, gender, and comorbidities with the exception of diabetic neuropathy, which was more prevalent among inpatients. Neither the percent reduction nor the absolute difference in HbA1c levels over the follow-up period differed significantly between groups. Conclusion: In our cohort of patients with uncontrolled diabetes, there was no statistical difference in outcomes between outpatient and inpatient groups. Given the lack of added benefit from inpatient care, future strategies should focus on optimizing outpatient monitoring and intervention programs to enhance adherence and achieve better long-term glycemic control.

22 May 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
HAHatice Zeynep Atlı
Hatice Zeynep Atlı
OAOsman Yağız Atlı
Osman Yağız Atlı
AKAyse Muge Karcioglu
Ayse Muge Karcioglu
MDMerve Tokatlı Doğan
Merve Tokatlı Doğan
GAGözde Şengül Ayçiçek
Gözde Şengül Ayçiçek
YGYavuz Kutay Gökçe
Yavuz Kutay Gökçe
Objective: The primary objective was to evaluate whether admission serum albumin predicts six-month all-cause mortality in older adult patients admitted to the intensive care unit (ICU) after simple fracture surgery, and to compare its predictive performance with the modified Nutrition Risk in the Critically Ill (mNUTRIC) score and the Nutrition Risk Screening 2002 (NRS-2002). The secondary objectives were to identify baseline predictors of six-month mortality and high-risk mNUTRIC classification. Methods: This retrospective cohort study included patients aged ≥65 years admitted to the ICU of a tertiary care hospital after surgery for a simple fracture between July and December 2024. Demographic data, comorbidities, admission laboratory values (including albumin, prealbumin, and 25-hydroxy vitamin D, the latter included as an adjunctive nutritional biomarker), APACHE II, SOFA, mNUTRIC, and NRS-2002 scores were recorded. Postoperative complications and admission durations were evaluated. Binomial logistic regression models were constructed for six-month all-cause mortality and nutritional risk group classification. Receiver operating characteristic (ROC) analysis with the Youden Index was performed to determine cutoff values. Results: A total of 172 patients (mean age 80.84 ± 7.72 years; 67.4% female) were analyzed. Six-month all-cause mortality was 22.7%. Serum albumin (OR 0.823, 95% CI 0.729–0.928, p = 0.002) and ICU admission duration (OR 1.413, 95% CI 1.101–1.812, p = 0.007) were independent predictors of six-month all-cause mortality, whereas mNUTRIC, NRS-2002, and vitamin D were not. Neither mNUTRIC nor NRS-2002 scores differed significantly between survivors and non-survivors. In nutritional risk group analysis, age (OR 1.117, p = 0.001) and APACHE II (OR 1.694, p = 0.001) were independent predictors of high mNUTRIC risk. Head-to-head ROC analysis for the primary outcome of six-month all-cause mortality showed that admission serum albumin (AUC 0.698, 95% CI 0.604–0.793) provided significantly better discrimination than mNUTRIC (AUC 0.570, DeLong p = 0.046) and NRS-2002 (AUC 0.550, DeLong p = 0.039). In a sensitivity model restricted to admission-time variables (albumin, age, APACHE II, vitamin D, Charlson Comorbidity Index), admission albumin remained an independent predictor (OR 0.830, 95% CI 0.747–0.923, p < 0.001) and age emerged as a further independent predictor (OR 1.062, p = 0.034). Conclusions: Serum albumin outperformed mNUTRIC and NRS-2002 in predicting six-month all-cause mortality among older adult post-fracture ICU patients. Because neither mNUTRIC nor NRS-2002 discriminated between survivors and non-survivors, these scores alone cannot be recommended as mortality-prediction tools in this orthogeriatric ICU population. Whether admission albumin adds incremental value to existing nutritional scoring in this setting requires prospective, adequately powered validation.

27 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SASemih Aydemir
Semih Aydemir
YGYavuz Kutay Gökçe
Yavuz Kutay Gökçe
DŞDoğukan Şenberber
Doğukan Şenberber
TKTemel Kayan
Temel Kayan
YKYavuz Katırcı
Yavuz Katırcı
Recep DokuyucuRecep Dokuyucu
Recep Dokuyucu
Background/Objectives: We evaluated the Renal–Inflammatory–Nutritional–Metabolic Index (RIN-IM), a previously published 0–10-point composite biomarker score, for acute kidney injury (AKI) and renal replacement therapy (RRT) initiation in an independent intensive care unit (ICU) cohort. Methods: This retrospective study included 480 adults admitted to two ICUs between October 2023 and August 2026. RIN-IM was calculated within 24 h of admission from creatinine, albumin, systemic immune-inflammation index (platelet count × neutrophil count/lymphocyte count), pan-immune-inflammation value (neutrophil count × platelet count × monocyte count/lymphocyte count), and triglyceride–glucose index (triglyceride and admission glucose concentrations). Patients were classified by RIN-IM Score as low-risk (0–3 points), intermediate-risk (4–6 points), or high-risk (7–10 points). Among patients without AKI or acute RRT initiation at or before the 24-h landmark, subsequent incident AKI was the primary outcome and RRT initiation was the secondary renal outcome. Twenty-eight-day all-cause mortality was evaluated descriptively. Logistic regression and receiver operating characteristic analyses were performed. Results: AKI occurred in 189 patients (39.4%), RRT was initiated in 72 (15.0%), and 157 (32.7%) died within 28 days. In the low-, intermediate-, and high-risk groups, AKI frequencies were 16.0%, 40.0%, and 62.0%; RRT initiation frequencies were 3.3%, 12.2%, and 30.0%; and 28-day mortality was 18.0%, 32.2%, and 48.0%, respectively (all p < 0.001). Adjusted odds ratios per score point was 1.31 (95% confidence interval, 1.16–1.48) for AKI and 1.47 (1.25–1.73) for RRT initiation. Areas under the curve were 0.862 and 0.903, respectively, exceeding those of Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment. Conclusions: Higher RIN-IM scores were associated with AKI, RRT initiation, and higher observed 28-day mortality. The score may support early renal risk stratification, pending prospective assessment of calibration and clinical utility.